Clin Res Cardiol (2021) DOI DOI https://doi.org/10.1007/s00392-021-01843-w |
||
Regulation of basal and norepinephrine-induced cAMP in hiPSC-CM: Effects of culture conditions and comparison to adult human atrial myocytes | ||
D. Ismaili1, Z. Iqbal2, B. Dolce2, J. Petersen3, H. Reichenspurner3, A. Hansen2, P. Kirchhof1, T. Eschenhagen2, V. Nikolaev4, C. Espinosa Molina4, T. Christ2, für die Studiengruppe: DZHK | ||
1Klinik für Kardiologie, Universitäres Herz- und Gefäßzentrum Hamburg GmbH, Hamburg; 2Institut für Experimentelle Pharmakologie und Toxikologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg; 3Klinik und Poliklinik für Herz- und Gefäßchirurgie, Universitäres Herz- und Gefäßzentrum Hamburg GmbH, Hamburg; 4Zentrum für Experimentelle Medizin, Experimentelle Herz-Kreislaufforschung, Universitätsklinikum Hamburg-Eppendorf, Hamburg; | ||
Background There is ongoing interest in generating human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) to study human cardiac physiology and pathophysiology or to repair tissue. Recently we found calcium currents (ICa) stimulated by maximum concentrations of norepinephrine (NE) smaller in hiPSC-CM from conventional monolayers (ML) compared to integrated contracting engineered heart tissue (EHT). In order to elucidate culture specific regulation of β1-adrenoceptor (β1-AR) responses we investigated whether PDE-activity may limit NE effects on ICa and on cAMP in hiPSC-CM. Results were compared to adult human atrial myocytes (HAMs). Methods HAMs were isolated from tissue samples obtained during open heart surgery. All patients were on sinus rhythm. HiPSC-CM were dissociated from ML and EHT. Förster-resonance energy transfer (FRET) was used to monitor cytosolic cAMP (transduced by adenovirus, Epac1-camps sensor). ICa was recorded by whole-cell patch clamp technique. Cilostamide (300 nM) and rolipram (10 µM) were used to inhibit PDE3 and PDE4 respectively. β1-AR were stimulated with the natural agonist NE (100 µM). Results are presented as mean ± SEM. N/N indicates number of cells vs. number of batches for hiPSC-CM and number of cells/number patients for HAMs. Results In HAMs NE increased cAMP by 13.7±1.5% (n=10/9) and ICa by 10.4±1.5 pA/pF (n=15/10). Effects on both, cAMP and ICa, were not larger in the concomitant presence of rolipram, cilostamide and NE (FRET 15.5±1.8% n=12/10 and ICa 12.4±1.4 pA/pF n=17/6). In ML NE-induced increases in cAMP and ICa were significantly smaller than in HAMs (FRET 9.6±0.5% n=52/21 and ICa 1.4±0.2 pA/pF n=34/7, p<0.05 each). Notably, effects on cAMP as well as on ICa were larger in the presence of rolipram and NE (FRET 16.7±0.8% n=94/26 and ICa 5.6±1.4 pA/pF n=11/5, p<0.05 each). Cilostamide and NE increased FRET to a larger extent than NE alone (12.7±0.5% n=91/19, p<0.05). However, ICa responses were not increased (1.7±0.4 pA/pF n=9/5). In EHT NE responses on both, FRET and ICa, were larger than in ML (FRET 12.1±0.3% n=87/32 and ICa 3.3±0.2 pA/pF n=13/5, p<0.05 each). Effects of rolipram and NE on cAMP were not larger than with NE alone (FRET 11.2±0.7% n=87/26), while ICa responses were significantly increased to 6.2±1.6 pA/pF (p<0.05 vs. NE alone, n=10/4). Conclusion Our results show culture-dependent differences in hiPSC-CM. In conventional ML, but not in EHT maximum NE effects on cytosolic cAMP depend on PDE3 and PDE4, suggesting immaturity when compared to the situation in adult HAMs. The smaller ICa responses to NE in ML and EHT vs. adult HAMs depend at least partially on a non-physiological large impact of PDE4 in hiPSC-CM. |
||
https://dgk.org/kongress_programme/jt2021/aP355.html |